Pharmalot reports on Pfizer's attempts to boost lagging sales of Exubera, an insulin inhaler that apparently looks like a bong. I think the problem with a lot of medical blogging is that the pharmaceutical companies end up looking like the bad guys, so it prompts a fair amount of vitriol on the part of bloggers and readers. I mean, I'm sort of happy that Pfizer's product is failing. But, on the other hand, that product represents countless jobs, and most likely a source of revenue for other drugs that might be more popular and save more lives. How can I be so happy at the thought of someone taking the fall for this product?
Thursday, February 22, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment